Breaking down antibiotic resistance in methicillin-resistant Staphylococcus aureus: Combining antimicrobial photodynamic and antibiotic treatments (2022)

Peer-Reviewed Study · Willis JA; Cheburkanov V; Chen S; Soares JM; Kassab G; Blanco KC; Bagnato VS; de Figueiredo P; Yakovlev VV · August 29, 2022

Willis JA et al., 2022-08-29: US/Brazil study showing that methylene blue photodynamic therapy combined with chloramphenicol or tetracycline significantly re-sensitises two MRSA strains (USA300 and a second strain) to those antibiotics.

Performing aPDT with the photosensitizer methylene blue in combination with antibiotics chloramphenicol and tetracycline results in significant reductions in resistance for two methicillin-resistant Staphylococcus aureus (MRSA) strains, USA300 and

Abstract

Willis JA et al., 2022-08-29: US/Brazil study showing that methylene blue photodynamic therapy combined with chloramphenicol or tetracycline significantly re-sensitises two MRSA strains (USA300 and a second strain) to those antibiotics. Study type: in vitro bacteriology (MRSA strains USA300 and companion strain; aPDT plus antibiotic dose-response). Photosensitiser methylene blue; light parameters not in the abstract. Countries: USA (Texas A&M) and Brazil (Sao Carlos). Funding: NIGMS R01 GM127696, NCI R21 CA269099, NIGMS R21 GM142107. Conflicts: 'The authors declare no competing interest.' Bearing: supports the 'adjuvant to antibiotics' half of C9 with a mechanistic resistance-reversal result; laboratory only. Study type: lab.